Home
Jonathan McNeill, Chief Business Officer: Dyne Therapeutics DYN Sell · Filed 24/01/04
Trade details
- Type
- Insider sale
- Amount
- $196,009
- Shares · price
- 10,300 sh · $19.03 a share
- Held after
- 143,618 sh
- Trade date
- 24/01/03
- Filed
- 24/01/04
- Days to filing
- 1 days
Sold 6.7% of holdings
- Share of holding sold
- 6.7%
Dyne Therapeutics trades, last 26 weeks
What else happened in Dyne Therapeutics around then
Filed or reported within 30 days of the trade day · 23/12/04~24/02/02Jonathan McNeill's recent trades
- Jonathan McNeill
Planned sale10b5-1 planCrescent Biopharma
Planned sale10b5-1 planCrescent Biopharma
CBIO
$75.8K
4,415 sh
$75.8K
Filed 09/17
Traded 09/18
- Jonathan McNeill
Planned sale10b5-1 planCrescent Biopharma
Planned sale10b5-1 planCrescent Biopharma
CBIO
$15.1K
804 sh
$15.1K
Filed 09/16
Traded 09/16
- Jonathan McNeill
Sell10b5-1 planCrescent Biopharma
Sell10b5-1 planCrescent Biopharma
CBIO
$369.7K
20,549 sh
$369.7K
Filed 06/23
Traded 06/22
- Jonathan McNeill
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 planDyne Therapeutics
DYN
$108K
2,400 sh
$108K
Filed 24/08/20
Traded 24/08/19
- Jonathan McNeill
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 planDyne Therapeutics
DYN
$14K
305 sh
$14K
Filed 24/08/20
Traded 24/08/19
